Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxaverine effects on ocular blood flow
NCT00709423Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2007
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Moxaverine with Placebo (2 arms). Primary endpoints: Retinal blood flow at 2 hours and Choroidal and optic nerve head blood flow at 2 hours. Started Mar 2007; status: completed.
02
Drugs
moxaverine
Beyond the preview
Go deeper on NCT00709423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709423.